Tatsuya Suwabe1, Kyoko Fuse2, Kouji Katsura3, Marie Soga3, Takayuki Katagiri1, Yasuhiko Shibasaki1, Miwako Narita4, Hirohito Sone1, Masayoshi Masuko5. 1. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, 1-757 Asahimachi-dori Chuoh-ku, Niigata, 951-8510, Japan. 2. Department of Hematopoietic Cell Transplantation, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-dori Chuoh-ku, Niigata, 951-8510, Japan. kyo-fuse@med.niigata-u.ac.jp. 3. Department of Oral Radiology, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-dori Chuoh-ku, Niigata, 951-8510, Japan. 4. Laboratory of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, 2-746 Asahimachi-dori, Chuo-ku, Niigata, 951-8518, Japan. 5. Department of Hematopoietic Cell Transplantation, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-dori Chuoh-ku, Niigata, 951-8510, Japan.
Abstract
PURPOSE: Bloodstream infection (BSI) is a major complication of allogeneic hematopoietic stem-cell transplantation (allo-SCT). There are several causes of BSI; in particular, severe oral mucositis (OM) can induce BSI due to coagulase-negative staphylococci (CoNS). The OM severity may be reduced with intensive oral care. Thus, we evaluated whether the type of oral care affects the BSI incidence eventually. METHOD: We performed retrospective analysis on 206 recipients who underwent allo-SCT from 2006 to 2017 at our institute. Intensive oral care by a dental specialist was performed for 111 recipients (intensive-care group) and self-oral care was performed by 95 recipients (self-care group). Incidence of BSI was assessed by type of the oral care, before neutrophil engraftment (pre-E-BSI) and after neutrophil engraftment (post-E-BSI) period until 180 days after allo-SCT. RESULT: A total of 112 BSI occurred in 90 of the 206 recipients and 120 bacteria were identified, with CoNS being the most prevalent. There was no significant difference in the incidence of pre-E-BSI between the self-care and intensive-care groups (30.8% and 30.6%, respectively; P = 0.508). Meanwhile, the incidence of post-E-BSI was significantly lower in the intensive-care group than in the self-care group (14.3% and 28.6%; P = 0.008). In addition, the intensive-care group had significantly lower incidence of post-E-BSI with CoNS than the self-care group (8.5% and 21.5%, respectively; P = 0.009). CONCLUSION: Intensive oral care through the period of allo-HCT can significantly reduce the post-E-BSI occurrence, especially due to CoNS.
PURPOSE: Bloodstream infection (BSI) is a major complication of allogeneic hematopoietic stem-cell transplantation (allo-SCT). There are several causes of BSI; in particular, severe oral mucositis (OM) can induce BSI due to coagulase-negative staphylococci (CoNS). The OM severity may be reduced with intensive oral care. Thus, we evaluated whether the type of oral care affects the BSI incidence eventually. METHOD: We performed retrospective analysis on 206 recipients who underwent allo-SCT from 2006 to 2017 at our institute. Intensive oral care by a dental specialist was performed for 111 recipients (intensive-care group) and self-oral care was performed by 95 recipients (self-care group). Incidence of BSI was assessed by type of the oral care, before neutrophil engraftment (pre-E-BSI) and after neutrophil engraftment (post-E-BSI) period until 180 days after allo-SCT. RESULT: A total of 112 BSI occurred in 90 of the 206 recipients and 120 bacteria were identified, with CoNS being the most prevalent. There was no significant difference in the incidence of pre-E-BSI between the self-care and intensive-care groups (30.8% and 30.6%, respectively; P = 0.508). Meanwhile, the incidence of post-E-BSI was significantly lower in the intensive-care group than in the self-care group (14.3% and 28.6%; P = 0.008). In addition, the intensive-care group had significantly lower incidence of post-E-BSI with CoNS than the self-care group (8.5% and 21.5%, respectively; P = 0.009). CONCLUSION: Intensive oral care through the period of allo-HCT can significantly reduce the post-E-BSI occurrence, especially due to CoNS.
Authors: Jo-Anne H Young; Brent R Logan; Juan Wu; John R Wingard; Daniel J Weisdorf; Cathryn Mudrick; Kristin Knust; Mary M Horowitz; Dennis L Confer; Erik R Dubberke; Steven A Pergam; Francisco M Marty; Lynne M Strasfeld; Janice Wes M Brown; Amelia A Langston; Mindy G Schuster; Daniel R Kaul; Stanley I Martin; Claudio Anasetti Journal: Biol Blood Marrow Transplant Date: 2015-09-25 Impact factor: 5.742
Authors: M Kikuchi; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; K Sakamoto; K Kawamura; Y Ishihara; M Sato; M Ashizawa; K Terasako-Saito; S Kimura; R Yamazaki; J Kanda; S Kako; J Nishida; Y Kanda Journal: Transpl Infect Dis Date: 2015-01-12 Impact factor: 2.228
Authors: S Kurosawa; K Yakushijin; T Yamaguchi; Y Atsuta; T Nagamura-Inoue; H Akiyama; S Taniguchi; K Miyamura; S Takahashi; T Eto; H Ogawa; M Kurokawa; J Tanaka; K Kawa; K Kato; R Suzuki; Y Morishima; H Sakamaki; T Fukuda Journal: Bone Marrow Transplant Date: 2012-09-10 Impact factor: 5.483
Authors: Giampaolo Bucaneve; Alessandra Micozzi; Francesco Menichetti; Pietro Martino; M Stella Dionisi; Giovanni Martinelli; Bernardino Allione; Domenico D'Antonio; Maurizio Buelli; A Maria Nosari; Daniela Cilloni; Eliana Zuffa; Renato Cantaffa; Giorgina Specchia; Sergio Amadori; Francesco Fabbiano; Giorgio Lambertenghi Deliliers; Francesco Lauria; Robin Foà; Albano Del Favero Journal: N Engl J Med Date: 2005-09-08 Impact factor: 91.245
Authors: Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren A Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald Journal: N Engl J Med Date: 2010-11-25 Impact factor: 91.245
Authors: N G Almyroudis; A Fuller; A Jakubowski; K Sepkowitz; D Jaffe; T N Small; T E Kiehn; E Pamer; G A Papanicolaou Journal: Transpl Infect Dis Date: 2005-03 Impact factor: 2.228
Authors: Hafsa M Chaudhry; Alison J Bruce; Robert C Wolf; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Walter K Kremers; Gordon L Phillips; Shahrukh K Hashmi Journal: Biol Blood Marrow Transplant Date: 2015-09-26 Impact factor: 5.742
Authors: S Kurosawa; K Yakushijin; T Yamaguchi; Y Atsuta; T Nagamura-Inoue; H Akiyama; S Taniguchi; K Miyamura; S Takahashi; T Eto; H Ogawa; M Kurokawa; J Tanaka; K Kawa; K Kato; R Suzuki; Y Morishima; H Sakamaki; T Fukuda Journal: Bone Marrow Transplant Date: 2013-04-08 Impact factor: 5.483